Health Care/Hospital

Aphranel Convenes Cadaver Dissection Class in Thailand Successfully

BANGKOK, Jan. 14, 2026 /PRNewswire/ -- The inaugural "Moyom Biotech • Aphranel Global Expert Advisory Panel • Thailand Anatomy Exchange Conference" was successfully convened inThailand. This high-level forum gathered leading experts from multipleAsia-Pacific countries. Through this concentrated ...

2026-01-15 17:51 3369

Ericsson announces proposed headcount reduction in Sweden

STOCKHOLM, Jan. 15, 2026 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announces proposed staff reductions in Sweden as part of measures aimed at ensuring the Company's competitive position. The proposed staff reduction is part of global initiatives to improve cost position while maintaining inv...

2026-01-15 17:04 3701

MediCapture Launches aiScope™ Pilot for Veterinary Sciences at VMX 2026

Medical AI Made Easy—From Lab to Real-World Training & Practical Use CHEROKEE, Texas, Jan. 15, 2026 /PRNewswire/ -- MediCapture Inc., a global leader in medical imaging systems, today announced the launch of aiScope™, software that runs Vision AI models in real-time, locally on MediCapture'sMTR ...

2026-01-15 17:00 4159

AMPLIFON IS A GLOBAL TOP EMPLOYER 2026

Only 17 companies worldwide have earned this recognition for their human resources management practices in 2026. Certification obtained for the first time in the Asia-Pacific region, together with confirmation in Europe, North America, and Latin America. Switzerland, India, China, and Singapore w...

2026-01-15 16:30 2522

XA Africa Rebrands to A54, Signaling a New Era for African Tech Investment

The rebranding signals a sharper focus on the African continent for this exclusive angel investor network SINGAPORE, Jan. 15, 2026 /PRNewswire/ -- XA Africa, the exclusive operator-led investment network founded by global technology veterans, today announced its official launch asA54. The rebran...

2026-01-15 16:00 4804

GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities

YONGIN, South Korea, Jan. 15, 2026 /PRNewswire/ -- GCCL, a leading South Korea -based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of Understanding (MOU) on the sidelines of the 44th Annual J.P. Morgan He...

2026-01-15 15:31 3086

/C O R R E C T I O N -- Informa Markets/

In the news release, "International Healthcare Week Returns to Thailand in 2026 with Expanded Industry Reach", issued on 15 January 2026 by Informa Markets. over PR Newswire, we are advised by the company that the testimonial featured on behalf of i-SENS, South Korea., the name mentioned should ...

2026-01-15 14:17 5721

Docquity Launches Engage™, an AI and Insights-Powered HCP Intelligence Engine for the Life Sciences Industry

SINGAPORE, Jan. 15, 2026 /PRNewswire/ -- Docquity , a leading health tech company in Asia, today announced the launch ofDocquity Engage™, an AI and Insights-powered market intelligence engine designed to help life sciences companies better understand and optimize engagement...

2026-01-15 13:00 6105

Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease

SHANGHAI, Jan. 15, 2026 /PRNewswire/ -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for AB...

2026-01-15 12:11 4412

JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth

* Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects * 209 new integrated projects in 2025 set a new record, with approximately 50% originating from U.S. clients * Complex modalities are WuXi Biologics' core growth engi...

2026-01-15 12:00 6230

Hyundai Bioscience Confirms Entry into U.S. FDA Phase 2 Trials for Broad-Spectrum Antiviral 'XAFTY' Following 2026 Biotech Showcase Consensus

- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war."  - Announces "One Drug, Two Tracks" strategy: Targeting Dengue in Vietnam and Respiratory Viruses (Flu, COVID, RSV) in the U.S. with the same drug.  - Dr. Davey Smith: "With this multi-v...

2026-01-15 11:34 4401

HNC Expo 2025 Concluded Successfully in Shenzhen, Next Stop Shanghai in June 2026

SHENZHEN, China, Jan. 15, 2026 /PRNewswire/ -- During December 16-18, 2025, the "Healthplex Expo, Natural & Nutraceutical Products Shenzhen" (HNC Shenzhen), co-organized by CCCMHPIE and Sinoexpo Informa Markets, was held successfully at the Shenzhen World Exhibition & Convention Center. With Shen...

2026-01-15 10:00 3730

AIM's Iterative Process High-Efficiency Diploid Rabies Vaccine Completes Phase III Clinical Trials, Efficacy Significantly Higher than Existing Market Products

HONG KONG, Jan. 15, 2026 /PRNewswire/ -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully completed the Phase III clinical site work. This marks th...

2026-01-15 08:30 5899

Heartstream Launched as Independent Emergency Care Company

Former Philips Emergency Care business becomes first platform company of Emergency Care Holdings, advancing a century-long mission to save lives BOTHELL, Wash., Jan. 15, 2026 /PRNewswire/ -- Emergency Care Holdings (ECH), a platform formed by Bridgefield Capital to assemble and grow category-lead...

2026-01-15 00:45 2441

Metabolon Appoints Celia Reyes as Vice President of Human Resources

Celia Reyes will lead Metabolon's global people strategy as the company continues to scale in the evolving multiomics marketplace MORRISVILLE, N.C., Jan. 14, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science resea...

2026-01-14 22:00 2957

Yuyu Pharma Establishes UCLA Office to Accelerate U.S. Pet Industry Expansion

SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ -- Yuyu Bio and Mervyn's Petcare, pet-focused subsidiaries of Yuyu Pharma, have opened a new office on theUCLA campus, strengthening the company's presence in the United States pet and animal health market. The two companies are now based at Magni...

2026-01-14 22:00 4615

NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Saudi Biotech Alliance Summit Begins in SF

NEW YORK, Jan. 14, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Saudi ...

2026-01-14 21:55 7420

iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System

ST. PAUL, Minn., Jan. 14, 2026 /PRNewswire/ -- iotaMotion, Inc ., creator of iotaSOFT®, the first and only FDA cleared robotic-assisted cochlear implant insertion system...

2026-01-14 21:03 3483

Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences

LOS GATOS, Calif., Jan. 14, 2026 /PRNewswire/ -- Lynx Analytics today announced  Lumen , a specialized Agentic AI framework designed to help pharmaceutical and biotech organizations generate strategic, decision-ready insights from c...

2026-01-14 21:00 3329

Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

HONG KONG, Jan. 13, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI), comparing cadonilimab plus chemotherapy against a PD-1 inhibitor plus chemotherapy for th...

2026-01-14 11:54 3991
1 ... 11121314151617 ... 858